Valuation: Avantor, Inc.

Market Cap 9.42B 8.16B 7.65B 6.98B 13.12B 899B 13.32B 89.95B 35.16B 450B 35.37B 34.61B 1,500B P/E 2026 *
41.7x
P/E 2027 * 29.9x
Enterprise Value 12.49B 10.82B 10.14B 9.25B 17.39B 1,192B 17.66B 119B 46.63B 597B 46.91B 45.89B 1,990B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.76x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 50 23/06/2026
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Date Insider Type Main position Quantity % Market Cap.
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
24/07/26 Tax

Compliance Officer

-1,201 0.0002%
23/02/26 Tax

Compliance Officer

2,376 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%+4.27% - - 9.42B
+1.05%+3.59%-13.57%+5.41% 192B
+0.50%+5.88%-2.09%+9.39% 116B
+0.16%-3.48%+7.79%+67.19% 59.95B
+2.11%+4.26%+33.94%+64.61% 54.64B
+0.88%+3.76%-6.24%-35.00% 50B
+0.38%+9.24%+13.42%-21.66% 34.26B
+0.99%+4.26% - - 31.15B
-0.87%+0.21%+41.87%-12.65% 24.79B
+0.85%+13.34%-6.26%+23.46% 24.07B
Average +0.68%+4.24%+8.61%+12.60% 59.64B
Weighted average by Cap. +0.82%+4.27%+0.92%+13.40%

Financials

2026 *2027 *
Net sales 6.59B 5.71B 5.35B 4.88B 9.18B 629B 9.32B 62.95B 24.61B 315B 24.76B 24.22B 1,050B 6.75B 5.85B 5.48B 5B 9.4B 644B 9.54B 64.44B 25.19B 322B 25.34B 24.79B 1,075B
Net income 225M 195M 183M 167M 313M 21.47B 318M 2.15B 840M 10.75B 845M 827M 35.85B 311M 269M 252M 230M 433M 29.64B 439M 2.97B 1.16B 14.84B 1.17B 1.14B 49.49B
Net Debt 3.07B 2.66B 2.49B 2.27B 4.28B 293B 4.34B 29.33B 11.47B 147B 11.54B 11.28B 489B 2.44B 2.12B 1.98B 1.81B 3.4B 233B 3.45B 23.31B 9.11B 117B 9.17B 8.97B 389B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
13/08/26 US$13.87 -0.47% 394,964
12/08/26 US$13.93 +1.16% 6,196,739
11/08/26 US$13.77 +0.29% 7,644,967
10/08/26 US$13.73 +1.03% 6,427,950
07/08/26 US$13.59 +3.11% 6,218,151
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
13.93USD
Average target price
14.56USD
Spread / Average Target
+4.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock